MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 422 filers reported holding MEDIVATION INC in Q2 2016. The put-call ratio across all filers is 0.92 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $603,000 | -95.1% | 10,000 | -96.2% | 0.24% | -94.5% |
| Q1 2016 | $12,185,000 | +404.1% | 265,000 | +430.0% | 4.46% | +461.6% |
| Q4 2015 | $2,417,000 | -18.8% | 50,000 | -28.6% | 0.80% | -32.1% |
| Q3 2015 | $2,975,000 | -7.8% | 70,000 | +180.0% | 1.17% | -13.8% |
| Q1 2015 | $3,227,000 | +237.2% | 25,000 | +66.7% | 1.36% | +149.0% |
| Q4 2013 | $957,000 | – | 15,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $158,535,000 | 79.84% |
| Cormorant Asset Management, LP | 546,900 | $34,903,000 | 10.13% |
| BB BIOTECH AG | 1,479,706 | $94,435,000 | 5.04% |
| PFM Health Sciences, LP | 2,719,859 | $173,581,000 | 3.49% |
| Partner Investment Management, L.P. | 219,981 | $14,039,000 | 3.19% |
| Orbimed Advisors | 3,123,500 | $199,342,000 | 2.93% |
| Antipodean Advisors LLC | 525,000 | $33,506,000 | 2.90% |
| Eventide Asset Management | 134,800 | $8,603,000 | 2.65% |
| Bain Capital Public Equity Management, LLC | 1,428,117 | $91,142,000 | 2.58% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 257,055 | $16,405,000 | 2.52% |